Aclarion, Inc. (ACON)
Scans spinal discs with MRI to detect degenerative disc disease and pain levels
$2.12-0.05%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-69.7%
The outlook
ACON is trading near its 52-week low and well below both its 50- and 200-day moving averages, signaling a downtrend. Analyst sentiment leans bearish overall, though the average price target sits substantially above the current price at $2.12. The stock remains in a weak technical position despite the optimistic target gap.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +254% vs current price
Market cap
$5.2M
52-wk high
$12.03
52-wk low
$2.07
50-day avg
$3.00
200-day avg
$4.33
Trailing P/E
—